The technology allows for the destruction of tumors without surgery or radiation, as well as the treatment of uterine fibroids. More than 7,000 patients have been treated this way for uterine fibroids. The less invasive the procedure, the easier the recovery.
“Beyond its potential to treat disease or relieve symptoms of disease, patients have provided testimony that focused ultrasound offers them and their families something almost as important: improved quality of life,” Dr. Medan said. “It has a transformative impact.”
Related Articles on Medical Devices:
Minnesota Trade Group Signs with FDA to Improve Medical Device Approval Process
CMS Targets Unnecessary Medical Technology, Devices
Global Medical Device Market Will Reach $350B by 2016
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
